CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 884546
SAN FRANCISCO, CA
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,532,910
+$1,157,055 QoQ
Shares Held
2,353,291
+0.1% QoQ
Ownership
0.921%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 316 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. BCRX ranks #15 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,003,981 | $287,726,073 | |
| 2 | VTRS |
Viatris Inc
|
13,567,342 | $215,449,390 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
974,279 | $164,204,982 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
297,162 | $161,011,285 | |
| 5 | ALKS |
Alkermes plc.
|
2,335,117 | $122,360,130 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,553,213 | $87,444,571 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
2,453,787 | $85,072,795 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
665,457 | $73,825,799 |
All Filings in BCRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,532,910 | 2,353,291 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,375,855 | 2,350,405 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,638,524 | 2,004,939 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $15,137,526 | 1,994,404 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $17,650,080 | 1,969,875 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $14,889,539 | 1,979,992 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $14,348,754 | 1,887,994 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $11,032,128 | 1,785,134 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $8,797,559 | 1,731,803 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,550,671 | 1,594,436 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $10,342,513 | 1,460,807 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $10,147,491 | 1,441,405 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $11,868,820 | 1,423,120 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $16,306,042 | 1,420,387 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $17,465,464 | 1,386,148 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,357,091 | 1,357,003 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $21,899,634 | 1,346,841 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $17,656,187 | 1,274,815 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $17,878,665 | 1,244,166 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $19,400,624 | 1,227,111 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,274,844 | 1,206,966 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,706,747 | 1,168,691 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,024,958 | 1,170,046 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,417,013 | 927,944 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $1,718,014 | 859,007 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||